Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK –positive anaplastic large-cell lymphoma

Christine Damm-Welk, Kerstin Busch, Birgit Burkhardt, Jutta Schieferstein, Susanne Viehmann, Ilske Oschlies, Wolfram Klapper, Martin Zimmermann, Jochen Harbott, Alfred Reiter, Willi Woessmann

Blood (2007) 110 (2): 670–677.

https://doi.org/10.1182/blood-2007-02-066852

Published: 2007

Includes: Supplemental data

Journal Articles

RANBP2/ALK Rearrangement Is a New Rare but Recurrent Fusion Gene in Childhood Myeloid Disorders.

Jochen Harbott, PhD, Jochen Bruch, PhD, Kerstin Busch, PhD, Ulrike A. Gammerdinger, PhD, Silja Rottgers, PhD, Andrea Teigler-Schlegel, PhD, Susanne Viehmann, PhD

Blood (2005) 106 (11): 485.

https://doi.org/10.1182/blood.V106.11.485.485

Published: 2005

Journal Articles

BCR Gene Breakpoint and Type of BCR/ABL-Transcript in Children with Chronic Myeloid Leukemia.

Meinolf Suttorp, Susanne Viehmann, Alexander Claviez, Yvonne Martiniak, MA, Jochen Harbott

Blood (2005) 106 (11): 4863.

https://doi.org/10.1182/blood.V106.11.4863.4863

Published: 2005

Journal Articles

Gain of Chromosome 21 Is Associated with Early Treatment Sensitivity in Childhood Acute Lymphoblastic Leukemia.

Doris Steinemann, Gunnar Cario, Martin Stanulla, Marcel Tauscher, Tanja Hinrichsen, Gudrun Michaelsen, Susanne Viehmann, Peter Lichter, Martin Schrappe, Brigitte Schlegelberger

Blood (2005) 106 (11): 1440.

https://doi.org/10.1182/blood.V106.11.1440.1440

Published: 2005

Journal Articles

Frequent Loss of the SLP-65 Adapter Protein in Childhood Acute B-Precursor Lymphoblastic Leukemia (ALL) with TEL/AML1 Rearrangement.

Arndt Borkhardt, MD, Christine Damm-Welk, PhD, Thomas Wossning, PhD, Bettina Storch, PhD, Uta Fuchs, PhD, Susanne Viehmann, PhD, Jochen Harbott, PhD, Martin Zimmermann, PhD, Wolf-Dieter Ludwig, MD, Martin Schrappe, MD, Michael Reth, PhD, Hasan Jumaa, PhD

Blood (2005) 106 (11): 741.

https://doi.org/10.1182/blood.V106.11.741.741

Published: 2005

Journal Articles

Prognostic Factors in CD10 Negative Precursor B-Cell Acute Lymphoblastic Leukemia in Children: Data from Three Consecutive Trials ALL-BFM 86, 90, and 95.

Anja Möricke, MD, Richard Ratei, MD, Wolf-Dieter Ludwig, MD, PhD, Jochen Harbott, PhD, Arndt Borkhardt, MD, PhD, Susanne Viehmann, PhD, Martin Zimmermann, PhD, Helmut Gadner, MD, PhD, Hansjörg Riehm, MD, PhD, Martin Schrappe, MD, PhD

Blood (2004) 104 (11): 1957.

https://doi.org/10.1182/blood.V104.11.1957.1957

Published: 2004

Journal Articles

The Expression of the Adaptor Protein SLP-65 Is Freqently Lost in Childhood B-Lineage Acute Lymphoblastic Leukemia (ALL).

Arndt Borkhardt, MD, Christine Damm-Welk, PhD, Jochen Harbott, PhD, Thomas Wossning, PhD, Bettina Storch, PhD, Uta Fuchs, PhD, Martin Zimmermann, PhD, Susanne Viehmann, PhD, Wolf-Dieter Ludwig, MD, Martin Schrappe, MD, Hassan Jumaa, PhD

Blood (2004) 104 (11): 1118.

https://doi.org/10.1182/blood.V104.11.1118.1118

Published: 2004

Journal Articles

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia

Bernard M. Fine, Martin Stanulla, Martin Schrappe, Minh Ho, Susanne Viehmann, Jochen Harbott, Linda M. Boxer

Blood (2004) 103 (3): 1043–1049.

https://doi.org/10.1182/blood-2003-05-1518

Published: 2004

Includes: Supplemental data

Journal Articles

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

Daniel Steinbach, Susann Wittig, Gunnar Cario, Susanne Viehmann, Angelika Mueller, Bernd Gruhn, Ralf Haefer, Felix Zintl, Axel Sauerbrey

Blood (2003) 102 (13): 4493–4498.

https://doi.org/10.1182/blood-2002-11-3461

Published: 2003

Journal Articles

Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Michael Dördelmann, Alfred Reiter, Arndt Borkhardt, Wolf-Dieter Ludwig, Nicolai Götz, Susanne Viehmann, Helmut Gadner, Hansjörg Riehm, Martin Schrappe

Blood (1999) 94 (4): 1209–1217.

https://doi.org/10.1182/blood.V94.4.1209

Published: 1999

Journal Articles

Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials

Arndt Borkhardt, Giovanni Cazzaniga, Susanne Viehmann, Maria Grazia Valsecchi, Wolf Dieter Ludwig, Linda Burci, Silvia Mangioni, Martin Schrappe, Hansjörg Riehm, Fritz Lampert, Giuseppe Basso, Giuseppe Masera, Jochen Harbott, Andrea Biondi

Blood (1997) 90 (2): 571–577.

https://doi.org/10.1182/blood.V90.2.571

Published: 1997

NARROW

Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK –positive anaplastic large-cell lymphoma

RANBP2/ALK Rearrangement Is a New Rare but Recurrent Fusion Gene in Childhood Myeloid Disorders.

BCR Gene Breakpoint and Type of BCR/ABL-Transcript in Children with Chronic Myeloid Leukemia.

Gain of Chromosome 21 Is Associated with Early Treatment Sensitivity in Childhood Acute Lymphoblastic Leukemia.

Frequent Loss of the SLP-65 Adapter Protein in Childhood Acute B-Precursor Lymphoblastic Leukemia (ALL) with TEL/AML1 Rearrangement.

Prognostic Factors in CD10 Negative Precursor B-Cell Acute Lymphoblastic Leukemia in Children: Data from Three Consecutive Trials ALL-BFM 86, 90, and 95.

The Expression of the Adaptor Protein SLP-65 Is Freqently Lost in Childhood B-Lineage Acute Lymphoblastic Leukemia (ALL).

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia

The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype

Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia

Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy Trials

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only